secwatch.observer — SEC 8-K summary
======================================

Issuer:     AGENUS INC (AGEN)
CIK:        0001098972
Form:       8-K
Filed at:   2023-03-30T23:59:59+00:00
Accession:  0001193125-23-084699
Event type: other_material
Sentiment:  positive
Materiality: 0.65
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Agenus declares dividend of 5M shares of MiNK Therapeutics to shareholders
--------------------------------------------------------------------------

- Record date April 17, 2023; payment no earlier than April 27 and no later than May 17, 2023.
- Pro rata distribution; no fractional shares; cash in lieu based on MiNK closing price on record date.
- CEO Garo Armen says dividend demonstrates commitment to delivering additional shareholder value.
- MiNK to present updated clinical data for agenT-797 at AACR Annual Meeting April 14-19, 2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1098972/000119312523084699/0001193125-23-084699-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1098972/000119312523084699/d480291d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-084699

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer